Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Coronary Artery Disease (CAD)
Clinical trial register · United States · industry-sponsored

Coronary Artery Disease (CAD) Trials in the USA, 2026

Every industry-sponsored study on the ClinicalTrials.gov registry that lists a US site and is open, about to open, active-but-closed, or enrolling by invitation. This deliberately excludes academic and other non-industry sponsors — the full US registry across all sponsors runs to over 22,000 recruiting studies alone.

Download CSV
Source: ClinicalTrials.gov. Complete coverage of the industry-sponsored slice — all 9183 matching records are in this view (non-industry sponsors are out of scope by design, not truncated). Synced 01 Nov 2026, 03:16 UTC
9183
Studies in scope
industry-sponsored, all four open statuses
4981
Recruiting now
open to new participants
2200
Lead sponsors
across recruiting studies
Top states
Georgia 1 Colorado 1
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
HeartFlow, Inc.2 Heart Input Output Inc1 EBI Anti Sepsis BV1 XyloCor Therapeutics, Inc.1 SB Technology, Inc.1 Clear sponsor filter
State
Georgia1 Colorado1
All 2 states
Target enrolment
to

Coronary Artery Disease (CAD) trials in the USA

2 of 9183 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
US states
Start
Recruiting
HeartFlow, Inc.
Observational
5,000
Georgia
2026-03-11
Recruiting
Using CTA Measures to Define Cardiac Risk In NFL Alumni
NCT06831409Coronary Artery Disease (CAD), Heart Disease, Coronary Atherosclerosis
HeartFlow, Inc.
Observational
300
Colorado
2024-12-17
Rows per page Showing 1–2 of 2
1
Cite this view

Priya Life Science (2026). Clinical trial register: industry-sponsored studies with a US investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 1 November 2026. https://priyalifescience.com/clinical-trials-usa/condition/coronary-artery-disease-cad

Query this register directly
GET /api/trials?country=usa&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every industry-sponsored study on the registry that lists at least one investigative site in the US and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,183 studies in total at the last sync on 01 Nov 2026, 03:16 UTC. Academic and other non-industry sponsors are out of scope by design. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 2 of those studies listing the condition Coronary Artery Disease (CAD) that also match the filters currently applied.

How many Coronary Artery Disease (CAD) trials are recruiting in the US?

2 of the 2 studies on this page are recruiting new participants as of the 01 Nov 2026, 03:16 UTC sync. A further 0 have not yet opened recruitment, 0 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Coronary Artery Disease (CAD)), 2 studies
PhaseStudiesRecruitingShare
Observational22100%

Most active sponsors

Lead sponsors with the most studies (Coronary Artery Disease (CAD))
Lead sponsorStudiesRecruiting
HeartFlow, Inc.22

Top states

Top states (Coronary Artery Disease (CAD)), by number of studies with a site there
StateStudies
Colorado1
Georgia1
Listing here is informational and not medical advice; eligibility is determined by each study team. Compare pay for the teams running these studies in the US Pharma Salary Guide, see who's behind them in the US Company Directory, or track approvals on the FDA Approvals Tracker. For Irish, UK and EU sites, see the Ireland, UK and EU registers.